Literature DB >> 3492992

Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123.

K A Johnson, S T Mueller, T M Walshe, R J English, B L Holman.   

Abstract

We used single photon emission computed tomography (SPECT) to study 15 patients with Alzheimer's disease and nine controls. Iofetamine hydrochloride I 123 uptake data were recorded from the entire brain using a rotating gamma camera. Activity ratios were measured for the frontal, posterior parietal, posterior, medial, and lateral cortical temporal regions and striate cortex and were normalized by the activity in the cerebellum. Abnormalities in iofetamine hydrochloride I 123 activity were similar to the abnormalities in glucose metabolism observed with positron emission tomography. Cortical tracer activity was globally depressed in patients with Alzheimer's disease, with the greatest reduction in the posterior parietal cortex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492992     DOI: 10.1001/archneur.1987.00520140035014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  29 in total

1.  Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using 99m technetium-hexamethylpropylene amine oxime and single photon emission tomography.

Authors:  P Goulding; A Burjan; R Smith; R Lawson; J Snowden; B Northen; D Neary; H Testa
Journal:  Eur J Nucl Med       Date:  1990

2.  Clinical and cerebral blood flow studies in patients with intracranial hemorrhage and amyloid angiopathy typical of Alzheimer's disease.

Authors:  H M Mehdorn; L Gerhard; S P Müller; H M Olbrich
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

Review 3.  Molecular neuroimaging in Alzheimer's disease.

Authors:  William Jagust
Journal:  NeuroRx       Date:  2004-04

4.  Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls.

Authors:  Dorit Merhof; Pawel J Markiewicz; Günther Platsch; Jerome Declerck; Markus Weih; Johannes Kornhuber; Torsten Kuwert; Julian C Matthews; Karl Herholz
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

5.  The investigation of Alzheimer's disease with single photon emission tomography.

Authors:  A Burns; M P Philpot; D C Costa; P J Ell; R Levy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

6.  Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.

Authors:  H Karbe; A Kertesz; J Davis; B J Kemp; F S Prato; R L Nicholson
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

7.  SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.

Authors:  M Lehtovirta; H Soininen; M P Laakso; K Partanen; S Helisalmi; A Mannermaa; M Ryynänen; J Kuikka; P Hartikainen; P J Riekkinen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

8.  (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type.

Authors:  U Spampinato; M O Habert; J L Mas; M C Bourdel; M Ziegler; J de Recondo; S Askienazy; P Rondot
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

9.  Examining the multifactorial nature of cognitive aging with covariance analysis of positron emission tomography data.

Authors:  Karen L Siedlecki; Christian G Habeck; Adam M Brickman; Yunglin Gazes; Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2009-08-27       Impact factor: 2.892

10.  White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI.

Authors:  Yu Zhang; Norbert Schuff; An-Tao Du; Howard J Rosen; Joel H Kramer; Maria Luisa Gorno-Tempini; Bruce L Miller; Michael W Weiner
Journal:  Brain       Date:  2009-05-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.